The Department of Justice approved Cigna’s acquisition of Express Scripts on Monday, saying the move was “unlikely to result in harm to competition or consumers.” Yet there are plenty of concerns in the marketplace. Some say the deal will drive efficiency and produce savings, while others warn its detrimental effects need to be nipped in the bud.
The Department of Justice approved Cigna’s acquisition of Express Scripts. What now?
